Clinical Trial Update: Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating SYP-0704A in combination with Taxotere (docetaxel) in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SYP-0704A
• Taxotere (docetaxel)

Snippet

Sponsor: Samyang Biopharmaceuticals Corporation | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED